Lilly to Test Obesity Drugs to Treat Addiction in 2025 (Correct)

Eli Lilly & Co. will begin studies to see if its blockbuster weight-loss medicines are also effective at controlling addictive behaviors like alcohol abuse, smoking and drug addiction, Chief Executive Officer Dave Ricks said.

The drugs are “anti-hedonics,” Ricks said Tuesday during an interview with David Rubenstein at a meeting of the Economics Club in Washington, DC, and may offer patients respite from their dependence. Some doctors already swear by the shots to help ease cravings, and Lilly’s rival Novo Nordisk A/S said earlier this year that it was planning a study that will look at whether its weight-loss drugs ...